Preparation and Vasodilation Mechanism of Angiotensin-I-Converting Enzyme Inhibitory Peptide from Ulva prolifera Protein
Marine Drugs · 2024
DOI: 10.3390/md22090398 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2024. Verfasst von Zhiyong Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Biology & Basic Medical Sciences, Soochow University, Suzhou 215101, China. Hauptthemen laut MEDLINE: Ulva, Angiotensin-Converting Enzyme Inhibitors, Peptides, Molecular Docking Simulation. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions.
Abstract (Originalsprache)
Ulva prolifera, a type of green algae that can be consumed, was utilized in the production of an angiotensin-I converting enzyme (ACE) inhibitory peptide. The protein from the algae was isolated and subsequently hydrolyzed using a neutral protease. The resulting hydrolysate underwent several processes including Sephadex-G100 filtration chromatography, ultrafiltration, HPLC-Q-TOF-MS analysis, ADMET screening, UV spectrum detection test, molecular docking, and molecular dynamic simulation. Then, the ACE inhibitory peptide named KAF (IC50, 0.63 ± 0.26 µM) was identified. The effectiveness of this peptide in inhibiting ACE can be primarily attributed to two conventional hydrogen bonds. Additionally, it could activate endothelial nitric oxide synthase (eNOS) activity to promote the generation of nitric oxide (NO). Additionally, KAF primarily increased the intracellular calcium (Ca2+) level by acting on L-type Ca2+ channel (LTCC) and the ryanodine receptor (RyR) in the endoplasmic reticulum, and completed the activation of eNOS under the mediation of protein kinase B (Akt) signaling pathway. Our study has confirmed that KAF has the potential to be processed into pharmaceutical candidate functions on vasoconstriction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biology & Basic Medical Sciences, Soochow University, Suzhou 215101, China.
- Suzhou Chien-Shiung Institute of Technology, Suzhou 215101, China.
- Key Laboratory of Functional Genomic and Molecular Diagnosis of Gansu Province, Lanzhou 730030, China.
ORCID-Profile: Aurang Zeb, Songdong Shen
Förderung
- National Natural Science Foundation of China
- Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions
Zitieren
APA
Li, Z., He, H., Liu, J., Gu, H., Fu, C., Zeb, A., Che, T., & Shen, S. (2024). Preparation and Vasodilation Mechanism of Angiotensin-I-Converting Enzyme Inhibitory Peptide from Ulva prolifera Protein. Marine Drugs. https://doi.org/10.3390/md22090398
Vancouver
Li Z, He H, Liu J, Gu H, Fu C, Zeb A, et al. Preparation and Vasodilation Mechanism of Angiotensin-I-Converting Enzyme Inhibitory Peptide from Ulva prolifera Protein. Marine Drugs. 2024. doi:10.3390/md22090398
BibTeX
@article{Li2024,
author = {Li, Zhiyong and He, Hongyan and Liu, Jiasi and Gu, Huiyue and Fu, Caiwei and Zeb, Aurang and Che, Tuanjie and Shen, Songdong},
title = {Preparation and Vasodilation Mechanism of Angiotensin-I-Converting Enzyme Inhibitory Peptide from Ulva prolifera Protein},
journal = {Marine Drugs},
year = {2024},
doi = {10.3390/md22090398}
}
EUVIMED